Literature DB >> 17529875

Effectiveness of pneumococcal conjugate vaccine in Greater Vancouver, Canada: 2004-2005.

Gordean Bjornson1, David W Scheifele, Julie Bettinger, David M Patrick, Larry Gustafson, Patricia Daly, Gregory J Tyrrell.   

Abstract

Active, population-based surveillance for invasive pneumococcal infections in Greater Vancouver (population 473,000 children) demonstrated a rapid, substantial decrease in incidence rates for children 6-23 months old with routine infant vaccination. In the subpopulation with best case ascertainment disease rates for 6-23 month olds decreased 84.6% (92.5% for vaccine serotypes).

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17529875     DOI： 10.1097/INF.0b013e31803c56df

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  5 in total

1.  Immunization in Canada: a 6-year update.

Authors:  Scott A Halperin; Kiersten Pianosi
Journal:  J Can Chiropr Assoc       Date:  2010-06

2.  Update on the Use of Conjugate Pneumococcal Vaccines in Childhood: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)†.

Authors:  Shalini Desai; Allison McGeer; Caroline Quach-Thanh; Denise Elliott
Journal:  Can Commun Dis Rep       Date:  2010-11-23

3.  Update on the success of the pneumococcal conjugate vaccine.

Authors:  Jd Kellner
Journal:  Paediatr Child Health       Date:  2011-04       Impact factor: 2.253

4.  Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada.

Authors:  Stephanie R Earnshaw; Cheryl L McDade; Giovanni Zanotti; Raymond A Farkouh; David Strutton
Journal:  BMC Infect Dis       Date:  2012-04-24       Impact factor: 3.090

Review 5.  Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children.

Authors:  Laura Conklin; Jennifer D Loo; Jennifer Kirk; Katherine E Fleming-Dutra; Maria Deloria Knoll; Daniel E Park; David Goldblatt; Katherine L O'Brien; Cynthia G Whitney
Journal:  Pediatr Infect Dis J       Date:  2014-01       Impact factor: 2.129
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.